This week’s most important N.J. cannabis stories: Industry event featuring Booker, hemp goes to the backburner, what employers should know

This week’s most important N.J. cannabis stories: Industry event featuring Booker, hemp goes to backburner, what employers should know

An article “ This week’s most important N.J. cannabis stories: Industry event featuring Booker, hemp goes to the backburner, what employers should know” recently published by N.J. Cannabis Insider staff explained Biomedican’s approach to biosynthesize cannabinoids. Dennis O’Neill stated biosynthesis as a significant opportunity for Biomedican because these rare cannabinoids are the next generation of CBD.

Biosynthesis of cannabinoids, which skips plant harvesting, is around the corner. While the hemp farmers are busy harvesting the plants, numerous entrepreneurs are busy finding ways to bypass the harvesting step and produce cannabinoids without a plant. Biomedican devised a more appealing biosynthesis method where plant genetics, sugar, yeast, and water are fermented to yield cannabinoids like CBG or CBD without producing THC. According to Dennis O’Neill, “All the federal and state regulations are around touching the plant and producing THC at any point in time, that creates a big opportunity for us because these rare cannabinoids are the next generations of CBGs.”

Twelve licensed medical cannabis companies of New Jersey were grouped into New Jersey Cannabis Trade Association. This association is striving to legalize the recreational use of marijuana by 21 and older. These licensed medical cannabis companies signed a joint statement and called for online ordering and home delivery to patients quarantined due to COVID-19.

The struggle of hemp farmers will become secondary with the legalization of marijuana by state. The actual yield of cannabinoids from hemp plants is badly affected by cold and dry weather, spiders, mites, and inchworm. According to an estimate, 130 hemp plants can yield 50 pounds of hemp. The plant products have contaminants like psychoactive compounds THC with them. In contrast, the biosynthesis method can produce cannabinoids rapidly, less costly, and contamination-free. We invite our readers to participate and invest in organic biosynthesis to create high-value cannabinoids efficiently. To learn more, head to our website

Publications

Contact us

Content author Dr.Saba IqbalAuthor posts

Saba Iqbal

Dr. Saba Iqbal is a contributing writer for BioMedican. She's a clinical pharmacist turned writer. Dr. Saba's education includes a doctoral degree in pharmacy (Pharm D) from the University of Sargodha, Pakistan. In search of a career that would take advantage of her medical and pharmaceutical skills, Dr. Saba found medical writing – a career path a few medical students consider. In her journey "from a medical bench to pen," she has worked with several startups for many years managing content on biotech products, pharmaceuticals, drugs, devices, and techniques. While keeping up with the latest trends in medical writing, she aims to use her writing skills to clearly communicate complex scientific, medical, and health information to the potential investor and general audience.